Anticoagulation Resumption After Colonic Polypectomy
Restart anticoagulation on the evening of the day of polypectomy (day 0) or within 48 hours post-procedure, balancing bleeding versus thrombotic risk. 1
Evidence-Based Timing
The BSG/ESGE guidelines explicitly state that warfarin should be resumed "on the day of the procedure with the usual daily dose that night" for patients who had temporarily discontinued anticoagulation 1. More broadly, the guidelines recommend that "antiplatelet or anticoagulant therapy...should be resumed up to 48 h after the procedure depending on the perceived bleeding and thrombotic risks" 1.
Critical Risk Stratification
Your decision on exact timing within this 0-48 hour window should be guided by:
High Bleeding Risk Scenarios (consider waiting closer to 48 hours):
- Multiple polyps ≥1 cm removed (OR 4.14 for bleeding) 2
- Use of fulguration/hot snare technique (OR 11.43 for bleeding) 2
- Large polyp size
- Complex polypectomy requiring extensive resection
High Thrombotic Risk Scenarios (restart same day/within 24 hours):
- Drug-eluting stents <12 months
- Bare metal stents <1 month
- Mechanical heart valves (especially mitral position)
- Atrial fibrillation with mitral stenosis
- Recent VTE (<3 months) 1
Key Research Findings
A 2022 post-hoc analysis of 437 patients provides crucial real-world data: Late resumption (>2 days) was associated with significantly higher thromboembolic events at 90 days (2.3% vs 0%) compared to early resumption, while bleeding rates were not significantly different (2.3% vs 0.9%, p=0.26) 2. The timing of anticoagulation resumption was NOT a significant predictor of bleeding on multivariate analysis 2.
A 2014 Japanese study found that resuming anticoagulants within 5 days was associated with increased bleeding risk (OR 10.2), but notably, resuming thienopyridines (like clopidogrel) within 5 days was NOT associated with increased bleeding 3. This suggests different anticoagulants may have different safety profiles for early resumption.
Practical Algorithm
For LOW thrombotic risk patients:
- Resume anticoagulation 24-48 hours post-polypectomy
- If complex polypectomy (multiple large polyps, fulguration used), wait closer to 48 hours
For HIGH thrombotic risk patients:
- Resume anticoagulation evening of procedure (day 0)
- Accept slightly higher bleeding risk given catastrophic consequences of thromboembolism
- Consider prophylactic clipping of polypectomy sites if available
For patients requiring bridging (high thrombotic risk):
- Restart warfarin evening of procedure
- Restart therapeutic LMWH the day after procedure
- Continue LMWH until therapeutic INR achieved 1
Critical Caveats
The consequences of thromboembolic events (stroke, MI, valve thrombosis) are typically catastrophic and irreversible, while post-polypectomy bleeding is generally manageable and rarely fatal 2. This asymmetry should bias your decision toward earlier resumption when in doubt.
Even with delayed resumption, patients on anticoagulation have inherently higher bleeding risk than non-anticoagulated patients—this risk persists regardless of timing 1. Counsel patients accordingly.
For DOACs specifically, the guidelines recommend resuming at least 48 hours post-procedure 1, though recent data from 2021 showed DOACs restarted at mean 1.6 days with only 1.6% delayed bleeding rate 4.